Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-15 Option Award | 2022-08-17 08:19 am | N/A 2032-08-14 | Magenta Therapeutics Inc. | MGTA | VASCONCELLES MICHAEL Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:18 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:14 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:14 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Humphrey Jeffrey Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:13 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks | 187,500 | $0 | 187,500 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:13 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Nichols David Wayne CTO | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:11 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks | 130,000 | $0 | 130,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:11 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2022-08-01 Option Award | 2022-08-01 9:10 pm | N/A 2032-07-31 | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 7:28 pm | N/A 2032-06-27 | Magenta Therapeutics Inc. | MGTA | Booth Bruce Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 6:37 pm | N/A 2032-06-27 | Magenta Therapeutics Inc. | MGTA | Daniel Thomas O Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 6:36 pm | N/A 2032-06-27 | Magenta Therapeutics Inc. | MGTA | Lawton Alison Frances Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 6:34 pm | N/A 2032-06-27 | Magenta Therapeutics Inc. | MGTA | RONNEBERG AMY L Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 6:34 pm | N/A 2032-06-27 | Magenta Therapeutics Inc. | MGTA | Albers Jeffrey W. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 6:33 pm | N/A 2032-06-27 | Magenta Therapeutics Inc. | MGTA | Scadden David Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 6:33 pm | N/A 2032-06-27 | Magenta Therapeutics Inc. | MGTA | McGeorge Anne Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-06 4:06 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer | 3,000 | $0.99 | 17,264 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-06 4:05 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 3,000 | $0.99 | 16,762 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-06 4:05 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks | 3,000 | $0.99 | 941,954 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-06 4:05 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 3,000 | $0.99 | 16,897 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:24 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:23 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | Humphrey Jeffrey Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:23 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks | 162,500 | $0 | 162,500 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:22 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:20 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | Nichols David Wayne CTO | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:19 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:18 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 4:17 pm | N/A 2032-05-16 | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:31 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks | 187,500 | $0 | 187,500 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:22 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | Humphrey Jeffrey Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:20 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:20 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:18 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | Nichols David Wayne CTO | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:17 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:16 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks | 130,000 | $0 | 130,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 5:15 pm | N/A 2032-02-14 | Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks | 75,000 | $0 | 75,000 (Direct) | View |
| 2021-10-01 Option Award | 2021-10-04 4:34 pm | N/A 2031-09-30 | Magenta Therapeutics Inc. | MGTA | Humphrey Jeffrey Chief Medical Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2021-08-26 Other | 2021-09-23 4:47 pm | N/A N/A | Magenta Therapeutics Inc. | MGTA | Borisy Alexis Director | 4,100 | $0 | 8,200 (Direct) | View |